Franz michael Jantsch
Principal Investigator
Medizinische Universität Wien
I'm working on
7 months ago
RNA Editing, Molecular Medicine, Cardiovascular and Cancer Biology
About
Franz Michael Jantsch advances RNA editing and epitranscriptomics in cardiovascular and cancer biology. He holds a provisional patent on modified filamins and site-directed RNA editing, and has secured >$1.4M in European funding toward RNA-based therapeutics.
Partnering listings
Learn more
No Partnering listings yet
This innovator has not added partnering listings yet. For now, explore their publications, funding, and other profile details to identify promising topics to connect on.
Franz michael Jantsch
Principal Investigator
Medizinische Universität WienWork experience
Principal Investigator
Top industry applications
Cardiovascular health
Open to opportunities in
BiochemistryCell BiologyGeneticsMolecular BiologyMolecular Medicine
Last updated Mar 2026
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.